Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Real-world Study on the Efficacy and Safety of DS8201 in the Treatment of Metastatic Breast Cancer

NCT06914661 is registered in ClinicalTrials.gov with The First Hospital of Jilin University as lead sponsor.

NCT NCT06914661
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06914661 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Real-world Study on the Efficacy and Safety of DS8201 in the Treatment of Metastatic Breast Cancer
Lead sponsor
The First Hospital of Jilin University
Phase
Observational
Overall status
Enrolling by invitation
Start date
May 25, 2025
Completion date
October 30, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer metastatic, efficacy and safety